以医药生物制品业、电子业和信息技术业3个行业的上市高新技术企业为样本,以2007--2009年为数据窗口,考察了不同实际控制人类型企业中高管薪酬激励和股权激励对公司R&D投入的影响.研究结果表明:在最终控制人为国有性质的公司,高管薪酬激励与R&D投入间呈倒“U”型关系,在最终控制人为非国有性质的公司,高管薪酬激励与R&D投入不相关;高管股权激励在两种实际控制人类型的公司都能显著提高R&D投入,但非国有控制公司股权激励效应强于国有控制公司.
Based on the data of Chinese listed companies in pharmaceutical, electronic and IT industries from 2007 to 2009, it empirically investigates the effects of executive compensation incentive and equity incentive on R&D expendi- ture in listed companies of different ultimate controllers. The results show that the relationship between R&D expendi- ture and executive compensation incentive in state controlled companies presents a reverse U, while there is no signifi- cant relationship between the two in non-state controlled companies. Executive equity incentive enhances R&D expendi- ture in both types of companies, with stronger incentive effect in non-state controlled companies.